Addressing Critical Issues and Emerging TheRapEutics in TrAnsplanTation for COVID-19 - The TREAT-COVID Study

About This Study

The pandemic continues to be hard for many transplant recipients and their families and caregivers. COVID-19 vaccines are less effective for transplant recipients. This is due to their suppressed immune systems. As a result, transplant recipients who get COVID-19 are at a higher risk of hospitalization and death. Preventing severe disease in transplant recipients requires different strategies. A New Study The CDTRP’s COVID-19 research is centered on addressing patient, family, and caregiver priorities. We have engaged the transplant community to learn how research and policy can support the recovery of quality of life during COVID-19 and in future health concerns A new study examines how COVID-19 continues to affect child and adult transplant recipients and their families and caregivers living in Canada. CDTRP will work with 11 transplant centres in Canada. The aim is to create a flexible national plan to inform better policies and improve patient health. The study is called Addressing Critical Issues and Therapeutics Emerging in Transplantation in COVID-19 for Transplant Recipients (TREAT-COVID). This study will: Assess the safety and effectiveness of COVID-19 treatment options. Look at the physical and mental health of organ and stem cell transplant recipients. Analyze financial struggles of the transplant community associated with the pandemic Patients and their families can help by joining research studies. The information gathered from the TREAT-COVID study will be used to improve treatment plans, guide important decisions, and help everyone better understand COVID-19 and its impact on their lives